Monday, May 20, 2013 Last update: 12:43 AM
Company Tech News as it Breaks
OncoMed Pharmaceuticals
News articles for OncoMed Pharmaceuticals:
Thursday, March 7, 2013
- OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-52M51 (Anti-Notch1) in Solid TumorsOncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that patient dosing has begun in a Phase ... read more
Wednesday, January 2, 2013
- FDA Clears OncoMed’s Demcizumab (Anti-DLL4) to Resume Clinical Testing in the USOncoMed Pharmaceuticals, a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that the U.S. Food and Drug Administration (FDA) ... read more